Drug antagonism

Drug antagonism
Drug antagonists are drugs that compete for the available receptors. They may be noncompetitive and have no pharmacological effect of their own, or competitive in that they are capable of reversing or altering an effect already achieved.

Competitive antagonism: the antagonism which blocks or reverses the effects of an agonist, provided that the antagonist is given at an appropriate dosage. The antagonism is completely reversible, and an increase in the biophasic concentration of the agonist will overcome the effect of the antagonist.Noncompetitive antagonism: is when the antagonist removes the receptor or its response potential from the system; this may be by preventing the agonist from producing its effect at a receptor site by irreversible change to the receptor or its capacity to respond. The antagonism is not reversible by increasing the concentration of the agonist.

​Disclaimer. Pallipedia does not endorse or recommend any commercial products, processes, or services; therefore, their mention cannot be construed as such. Pallipedia should not be used as guidance to treatment and its purpose is to provide users with information to help them better understand conditions and the current range of approaches related to palliative care. Pallipedia urges health care providers and patients to always consult other relevant and up-to-date experts.